Surmodics Stock Investor Sentiment

SRDX Stock  USD 35.54  0.53  1.51%   
Slightly above 51% of SurModics' investors are presently thinking to get in. The analysis of overall sentiment of trading SurModics stock suggests that some investors are interested at this time. SurModics' investing sentiment can be driven by a variety of factors including economic data, SurModics' earnings reports, geopolitical events, and overall market trends.
  

SurModics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards SurModics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
3 days ago at thelincolnianonline.com         
Surmodics, Inc. Shares Sold by Olympiad Research LP
news
over a week ago at www.macroaxis.com         
Disposition of 2640 shares by Heine Lisa Wipperman of SurModics at 27.3 subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Barclays PLC Acquires Significant Stake in Surmodics Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Beryl Capital Management LLC Reduces Stake in Surmodics Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Disposition of 5275 shares by Bedoya Jose H of SurModics at 27.3 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Disposition of 5275 shares by Dantzker David of SurModics at 27.3 subject to Rule 16b-3
news
over two weeks ago at benzinga.com         
Top 3 Health Care Stocks Youll Regret Missing This Month
benzinga news
over two weeks ago at thelincolnianonline.com         
Barrington Research Cuts Earnings Estimates for Surmodics
news
over three weeks ago at finance.yahoo.com         
SurModics Loses -13.87 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
Yahoo News
over three weeks ago at massdevice.com         
Surmodics reports first clinical use of thrombectomy system
news
over three weeks ago at zacks.com         
SurModics Loses -13.87 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
zacks News
over three weeks ago at finance.yahoo.com         
Surmodics Announces Successful Early Clinical Use of Pounce XL Thrombectomy System, Suitable for Non...
Yahoo News
over three weeks ago at businesswire.com         
Surmodics Announces Successful Early Clinical Use of Pounce XL Thrombectomy System, Suitable for Non...
businesswire News
over three weeks ago at news.google.com         
Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up - Yahoo Finance
Google News at Macroaxis
over three weeks ago at businesswire.com         
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
businesswire News
Far too much social signal, news, headlines, and media speculation about SurModics that are available to investors today. That information is available publicly through SurModics media outlets and privately through word of mouth or via SurModics internal channels. However, regardless of the origin, that massive amount of SurModics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of SurModics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of SurModics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to SurModics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive SurModics alpha.

SurModics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 7009 shares by Timothy Arens of SurModics at .4426 subject to Rule 16b-3
11/26/2024
2
Disposition of 1312 shares by Sides Teri Woodwick of SurModics at .45 subject to Rule 16b-3
11/29/2024
3
Disposition of 959 shares by Charles Olson of SurModics at .91 subject to Rule 16b-3
12/04/2024
4
Disposition of 668 shares by Gordon Weber of SurModics at .91 subject to Rule 16b-3
12/12/2024
5
After Plunging -10.42 percent in 4 Weeks, Heres Why the Trend Might Reverse for SurModics
01/14/2025
6
Heres Why You Should Add Surmodics Stock to Your Portfolio Now
01/23/2025
7
Disposition of 7358 shares by Knight Susan E of SurModics at 27.3 subject to Rule 16b-3
01/24/2025
8
SurModics Fiscal Q1 Earnings Snapshot
01/30/2025
9
Surmodics Announces Successful Early Clinical Use of Pounce XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femor...
02/03/2025
10
Top 3 Health Care Stocks Youll Regret Missing This Month
02/06/2025
11
Beryl Capital Management LLC Reduces Stake in Surmodics Inc
02/14/2025
12
Disposition of 2640 shares by Heine Lisa Wipperman of SurModics at 27.3 subject to Rule 16b-3
02/18/2025

Additional Tools for SurModics Stock Analysis

When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.